UT Health San Antonio

A new center for the study of chronic infectious diseases aims to develop treatments for illnesses like Valley fever, tuberculosis, HIV, and Long COVID that disproportionately affect South Texas communities. Led by Dr. Barbara Taylor, the center seeks to attract top researchers and serve as a hub for clinical trials and community-focused care.

This week, UT Health San Antonio plans to unveil new findings and strategies with research, treatment, and policy in fighting cancer among Latino and all populations.

Be Well Texas was awarded $256 million by the Texas Health and Human Services Commission to administer medications like Naloxone for opioid use disorder treatment services and to continue offering recovery support services.

Additional related studies reported that “higher blood cortisol levels are linked to an increased likelihood of developing the disease.” But identifying early risk factors is key for intervention.

A new study conducted by UT Health San Antonio showed that sleeping nine hours or more per night is associated with worsening cognitive performance, most especially for those with depression.

A digital tool that uses artificial intelligence to analyze speech patterns could help doctors detect dementia in patients when other signs and symptoms are not perceptible.

They said they found a new strategy that allows the body to use its own protein receptors to help the drugs enter cells more efficiently.

A San Antonio researcher hopes to dispel myths about who is at risk for eating disorders while studying the interaction between binge eating disorder and food insecurity in older Hispanic women.

Researchers said firefighters are at a 9% higher risk of being diagnosed with cancer and 14% higher risk of dying from cancer.

A medication that appears to preserve brain function after a stroke will soon go into human trials. The San Antonio researcher who discovered the medication's potential more than two decades ago is still leading the team.